InsiderTrades.com logo
Robert Alexander net worth and biography
  • Phone
  • Email
  • Website

Robert Alexander Biography and Net Worth

CEO of Allakos
Dr. Alexander has been involved in the formation and leadership of numerous biotechnology companies. Dr. Alexander was CEO of ZS Pharma where he led the initial public offering and sale of ZS Pharma to AstraZeneca. Prior to ZS Pharma, Dr. Alexander was a Director at Alta Partners, a venture capital firm, and was also Executive Chairman and interim CEO of SARcode Bioscience. During his time at Alta Partners, he led investments in SARcode Bioscience (acquired by Shire), Lumena Pharmaceuticals (acquired by Shire), ZS Pharma (acquired by AstraZeneca), and Allakos. Prior to Alta Partners, Dr. Alexander was a Principal in MPM Capital’s BioEquities Fund. Robert joined MPM from Genentech, where he worked in the Business Development group.

Dr. Alexander is on the Board of Directors of Allena Pharmaceuticals. He holds a PhD from the University of North Carolina at Chapel Hill and a Bachelor of Science in Zoology from Miami University of Ohio.

What is Robert Alexander's net worth?

The estimated net worth of Robert Alexander is at least $19,366.85 as of January 2nd, 2014. Dr. Alexander owns 80,628 shares of Allakos stock worth more than $19,367 as of March 25th. This net worth evaluation does not reflect any other assets that Dr. Alexander may own. Additionally, Dr. Alexander receives a salary of $1,500,000.00 as CEO at Allakos. Learn More about Robert Alexander's net worth.

How old is Robert Alexander?

Dr. Alexander is currently 54 years old. Learn More on Robert Alexander's age.

What is Robert Alexander's salary?

As the CEO of Allakos Inc., Dr. Alexander earns $1,500,000.00 per year. Learn More on Robert Alexander's salary.

How do I contact Robert Alexander?

The corporate mailing address for Dr. Alexander and other Allakos executives is 975 ISLAND DRIVE SUITE 201, REDWOOD CITY CA, 94065. Allakos can also be reached via phone at (650) 597-5002 and via email at ir@allakos.com. Learn More on Robert Alexander's contact information.

Has Robert Alexander been buying or selling shares of Allakos?

Robert Alexander has not been actively trading shares of Allakos over the course of the past ninety days. Most recently, Robert Alexander sold 18,113 shares of the business's stock in a transaction on Friday, June 4th. The shares were sold at an average price of $89.64, for a transaction totalling $1,623,649.32. Learn More on Robert Alexander's trading history.

Who are Allakos' active insiders?

Allakos' insider roster includes Robert Alexander (CEO), Peter Hudson (Major Shareholder), Steven James (Director), Daniel Janney (Director), Robert More (Major Shareholder), Henrik Rassmussen (Insider), and Adam Tomasi (COO). Learn More on Allakos' active insiders.

Are insiders buying or selling shares of Allakos?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 87,064 shares worth more than $87,934.64. The most recent insider tranaction occured on June, 28th when CFO Harlan Baird Radford sold 87,064 shares worth more than $87,934.64. Insiders at Allakos own 16.1% of the company. Learn More about insider trades at Allakos.

Information on this page was last updated on 6/28/2024.

Robert Alexander Insider Trading History at Allakos

See Full Table

Robert Alexander Buying and Selling Activity at Allakos

This chart shows Robert Alexander's buying and selling at Allakos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total Insider BuyingTotal Insider Selling

Allakos Company Overview

Allakos logo
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Read More

Today's Range

Now: $0.24
Low: $0.24
High: $0.25

50 Day Range

MA: $0.38
Low: $0.24
High: $1.21

2 Week Range

Now: $0.24
Low: $0.23
High: $1.56

Volume

943,663 shs

Average Volume

995,969 shs

Market Capitalization

$21.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72